by Dr. Marinov | May 7, 2024 | peptides
Insulin-like growth factor I (IGF-1) is considered to act as a crucial regulator in the mechanisms of physiological growth, primarily synthesized in response to stimulation by growth hormone. Among its notable variants, Mechano Growth Factor (MGF) emerges as a...
by Dr. Marinov | Apr 18, 2024 | peptides
Triptorelin, a synthetic peptide closely resembling gonadotropin-releasing hormones (GnRH), may play a potential role in modulating reproductive function by influencing the synthesis and secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH)....
by Dr. Marinov | Feb 21, 2024 | peptides
AOD 9604 peptide, a synthetic analog of growth hormone (HGH), has emerged as a promising research agent in the realm of obesity and weight. Originating from the modification of the growth hormone’s last 16 amino acids (176-191), this peptide, alternatively known...
by Dr. Marinov | Feb 7, 2024 | peptides
PT-141 is a research peptide that has garnered interest due to its unique structure and potential interactions with specific types of cells and tissues. More specifically, PT-141 is a heptapeptide made of seven amino acids and has the following sequence:...
by Dr. Marinov | Jan 10, 2024 | peptides
Prostamax is a synthetic tetrapeptide (Lys-Glu-Asp-Pro) belonging to the Khavinson peptide family.(1) Recent investigations propose its potential for instigating primary reparative mechanisms across diverse tissues, particularly in the case of prostate cell cultures....
by Dr. Marinov | Jan 3, 2024 | peptides
SS-31, also recognized as MTP-131, represents a tetrapeptide that has attracted considerable attention in the research community due to its prospective implications in mitochondrial dysfunction.(1) Distinguishing itself with a distinctive cationic 3+ charge under...
